CIK 0001655923 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alpha Cognition Inc.
Sign in to watch- Ticker
- ACOG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (858) 344-4375
- Business address
- 1452 HUGHES RD., STE. 200, GRAPEVINE, TX, 76051
- Former names
- Neurodyn Cognition Inc.
- 4 Open-market buy 10% owner bought 32,090 shares at an average $8.28 ($265,820)
- 4 Open-market buy 10% owner bought 36,940 shares at an average $8.35 ($308,576)
- 4 Open-market buy 10% owner bought 19,050 shares at $8.69 ($165,634)
- 4 Open-market buy 10% owner bought 31,763 shares at an average $8.53 ($270,800)
- 4 Open-market buy 10% owner bought 123,918 shares at an average $8.57 ($1,062,506)
- 4 Open-market buy Director bought 10,000 shares at $9.62 ($96,200)
- 4 Open-market buy 10% owner bought 52,900 shares at an average $8.00 ($422,976)
- 4 Open-market buy 10% owner bought 130 shares at $7.90 ($1,027)
- 4 Open-market buy 10% owner bought 200,086 shares at an average $7.82 ($1,565,499)
- 4 Open-market buy 10% owner bought 152,533 shares at an average $6.40 ($976,490)
- 4 Open-market buy 10% owner bought 7,685 shares at an average $5.96 ($45,773)
- 4 Open-market buy 10% owner bought 30,728 shares at an average $5.98 ($183,692)
- 4 Open-market buy 10% owner bought 10,054 shares at $5.83 ($58,596)
- 4 Open-market buy 10% owner bought 73,738 shares at an average $5.90 ($434,714)
- 4 Open-market buy 10% owner bought 24,376 shares at an average $5.77 ($140,545)
- 4 Open-market buy Chief Operating Officer bought 3,500 shares at $5.76 ($20,160)
- 4 Open-market buy 10% owner bought 34,043 shares at an average $5.76 ($196,009)
- 4 Grant or award Director acquired 5,489 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 11,850 shares at an average $5.06 ($60,019)
Page 1 of 4 · 62 filings